Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice

被引:545
作者
Rada, C
Williams, GT
Nilsen, H
Barnes, DE
Lindahl, T
Neuberger, MS
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
[2] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England
关键词
D O I
10.1016/S0960-9822(02)01215-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: We have previously proposed that deamination of cytosine to uracil at sites within the immunoglobulin loci by activation-induced deaminase (AID) triggers antibody diversification. The pattern of diversification (phase 1 or 2 hypermutation, gene conversion, or switch recombination) is viewed as depending on the mode of resolution of the dU/dG lesion. A major resolution mode involves excising the uracil, an activity that at least four different enzymes can accomplish in the mouse. Results: Deficiency in LING uracil-DNA glycosylase alone is sufficient to distort the pathway of hypermutation in mice. In ung(-/-) animals, mutations at dC/dG pairs are dramatically shifted toward transitions (95%), indicating that the generation of abasic sites (which can induce transversions) has been inhibited. The pattern of substitutions at dA/dT pairs is unaffected. Class-switch recombination is substantially, but not totally, inhibited. Conclusions: The results provide strong support for the DNA deamination model for antibody diversification with respect to class-switching as well as hypermutation and, in the context of this model, suggest that (i) UNG is the major mouse DNA glycosylase responsible for processing the programmed dU/dG lesions within the immunoglobulin locus; (ii) the second (dAMT-biased) phase of mutation is probably triggered by recognition of the initiating dU/dG lesion; and (iii) switch recombination largely proceeds via formation of an abasic site, although (iv) an UNG-independent pathway of switch recombination exists, which could reflect action by another uracil-DNA glycosylase but might alternatively be explained by a distinct pathway of resolution, for example, one involving MSH2/MSH6 recognition of the dU/dG lesion.
引用
收藏
页码:1748 / 1755
页数:8
相关论文
共 38 条
  • [1] Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) or recombination-activating gene (RAG)1 activity
    Bemark, M
    Sale, JE
    Kim, HJ
    Berek, C
    Cosgrove, RA
    Neuberger, MS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) : 1509 - 1514
  • [2] DNA double-strand breaks: Prior to but not sufficient in targeting hypermutation
    Bross, L
    Muramatsu, M
    Kinoshita, K
    Honjo, T
    Jacobs, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09) : 1187 - 1192
  • [3] DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation
    Bross, L
    Fukita, Y
    McBlane, F
    Démollière, C
    Rajewsky, K
    Jacobs, H
    [J]. IMMUNITY, 2000, 13 (05) : 589 - 597
  • [4] Ku80 is required for immunoglobulin isotype switching
    Casellas, R
    Nussenzweig, A
    Wuerffel, R
    Pelanda, R
    Reichlin, A
    Suh, H
    Qin, XF
    Besmer, E
    Kenter, A
    Rajewsky, K
    Nussenzweig, MC
    [J]. EMBO JOURNAL, 1998, 17 (08) : 2404 - 2411
  • [5] Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase
    Di Noia, J
    Neuberger, MS
    [J]. NATURE, 2002, 419 (6902) : 43 - 48
  • [6] Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation
    Ehrenstein, MR
    Neuberger, MS
    [J]. EMBO JOURNAL, 1999, 18 (12) : 3484 - 3490
  • [7] Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination
    Ehrenstein, MR
    Rada, C
    Jones, AM
    Milstein, C
    Neuberger, MS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14553 - 14558
  • [8] Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase
    Haug, T
    Skorpen, F
    Aas, PA
    Malm, V
    Skjelbred, C
    Krokan, HE
    [J]. NUCLEIC ACIDS RESEARCH, 1998, 26 (06) : 1449 - 1457
  • [9] Identification of a new uracil-DNA glycosylase family by expression cloning using synthetic inhibitors
    Haushalter, KA
    Stukenberg, PT
    Kirschner, MW
    Verdine, GL
    [J]. CURRENT BIOLOGY, 1999, 9 (04) : 174 - 185
  • [10] The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites
    Hendrich, B
    Hardeland, U
    Ng, HH
    Jiricny, J
    Bird, A
    [J]. NATURE, 1999, 401 (6750) : 301 - 304